惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

量子位
雷峰网
雷峰网
博客园 - 三生石上(FineUI控件)
月光博客
月光博客
有赞技术团队
有赞技术团队
阮一峰的网络日志
阮一峰的网络日志
Last Week in AI
Last Week in AI
G
Google Developers Blog
腾讯CDC
B
Blog
Microsoft Azure Blog
Microsoft Azure Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
Microsoft Security Blog
Microsoft Security Blog
人人都是产品经理
人人都是产品经理
博客园_首页
T
Tailwind CSS Blog
C
Check Point Blog
博客园 - 【当耐特】
MongoDB | Blog
MongoDB | Blog
A
About on SuperTechFans
Y
Y Combinator Blog
L
LangChain Blog
Engineering at Meta
Engineering at Meta
GbyAI
GbyAI

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Henry Schein, Inc. (HSIC) Presents at Bank of America Glo...
2026-05-14 · via All Articles on Seeking Alpha

Henry Schein, Inc. (HSIC) Bank of America Global Healthcare Conference 2026 May 13, 2026 5:20 PM EDT

Company Participants

Frederick Lowery - CEO & Director
Ronald South - Senior VP & CFO

Conference Call Participants

Allen Lutz - BofA Securities, Research Division

Presentation

Allen Lutz
BofA Securities, Research Division

I run the health care tech and distribution sector here at Bank of America. We are very excited to have the Henry Schein management team here with us. We have CEO, Fred Lowery, and CFO, Ron South. Thank you both for joining us. Really appreciate the time.

Frederick Lowery
CEO & Director

Thanks for having us.

Ronald South
Senior VP & CFO

Thank you, Allen.

Question-and-Answer Session

Allen Lutz
BofA Securities, Research Division

Before we kick off, Fred, I would love to get a sense. Do you have any prepared comments or would you love to make any comments about your first quarter as a public company CEO.

Frederick Lowery
CEO & Director

Excellent. Thank you very much. No, it's 2 months in, and things just finished a month 2, and things are off to a good start. We had a good Q1. Really healthy growth in our dental market. Overall, growth was strong in our technology business. Growth was strong in our distribution business. We did see some softness in medical. But when you back out for flu, the underlying performance was actually -- was pretty good, mid-single digits in medical as well. So good start to the year. Margins were good in the quarter. So a nice expansion in margins.

We recommitted to our value creation delivery of $125 million run rate net by the end of the year and $200 million over the next several years -- next couple of years on a net basis. And we reconfirmed our guidance for 2026. So off to a